Viewing Study NCT05099666


Ignite Creation Date: 2025-12-24 @ 4:26 PM
Ignite Modification Date: 2025-12-25 @ 7:27 PM
Study NCT ID: NCT05099666
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-09
First Post: 2021-10-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Lurbinectedin + Doxorubicin In Leiomyosarcoma
Sponsor: Massachusetts General Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module